Cart
sales@molnova.com
Isovaleramide
CAS No. 541-46-8
Isovaleramide( NPS-1776 | NPS 1776 | NPS1776 | Isovaleramide )
Catalog No. M14938 CAS No. 541-46-8
Isovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 35 | In Stock |
|
| 100MG | 58 | In Stock |
|
| 500MG | 138 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsovaleramide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
-
DescriptionIsovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
-
In Vitro——
-
In Vivo——
-
SynonymsNPS-1776 | NPS 1776 | NPS1776 | Isovaleramide
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorAlcohol DHO
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number541-46-8
-
Formula Weight101.15
-
Molecular FormulaC5H11NO
-
Purity>98% (HPLC)
-
SolubilityEthanol: 20 mg/mL (197.72 mM); DMSO: 20 mg/mL (197.72 mM)
-
SMILESCC(C)CC(N)=O
-
Chemical Name3-Methylbutanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Giraldo SE, et al. Biomedica, 2010, 30(2), 245-250.
molnova catalog
related products
-
DSM421
DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against field isolates of both P. falciparum and P. vivax.
-
Enasidenib mesylate
Enasidenib mesylate (AG-221 mesylate) is a potent and selective IDH2 mutase inhibitor that promotes differentiation of leukemia myeloid cells for the treatment of acute myeloid leukemia.
-
Octanoic acid
CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.
